SYDNEY GRABAU: Open Payments
NPI 1013323740 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,482 in 139 payments from 26 companies in 2025. Trend: 2023 $2,346 · 2024 $3,212 · 2025 $2,482
Food & beverage: $2,439Education: $43
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $268 |
| ABBVIE INC. | 26 | $235 |
| Teva Pharmaceuticals USA, Inc. | 11 | $209 |
| MDD US Operations, LLC | 11 | $192 |
| JAZZ PHARMACEUTICALS INC. | 8 | $189 |
| SK Life Science, Inc. | 4 | $184 |
| Tonix Medicines, Inc. | 15 | $155 |
| LivaNova USA, Inc. | 7 | $144 |
| Neurelis, Inc. | 7 | $128 |
| Supernus Pharmaceuticals, Inc. | 5 | $92 |
Products named: Gocovri, ZEMBRACE SYMTOUCH, XYWAV, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, AUSTEDO XR, VALTOCO, XCOPRI, Nayzilam.
Industry payments across NY — which companies pay providers there.
